BDBM355899 1-(4-(2- aminopyrimidin-4- yl)-3-chlorophenyl)- 3-(2-chloro-7- isopropylpyrazolo[1, 5-a]pyrimidin-6- yl)urea::US9815842, Example 23
SMILES: CC(C)c1c(NC(=O)Nc2cnc(c(Cl)c2)-c2ccnc(N)n2)cnc2cc(Cl)nn12
InChI Key: InChIKey=RJNVCKHFDBAILB-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MALT lymphoma-associated translocation (MALT1) (Homo sapiens (Human)) | BDBM355899 (1-(4-(2- aminopyrimidin-4- yl)-3-chlorophenyl)- 3-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.00400 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description IC50 values of test compounds were determined with an enzyme activity assay using the C-domain of MALT1 (amino acids 329-824). The readout parameter ... | US Patent US9815842 (2017) BindingDB Entry DOI: 10.7270/Q24F1T0N | |||||||||||
More data for this Ligand-Target Pair |